Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, has been associated with the development of Kaposi's sarcoma, pleural effusion lymphoma, and multicentric Castleman's disease. KSHV is a double-stranded DNA virus that has been classified as a gammaherpesvirus. The viral genome is approx, 160 kb long and encodes for several genes that are involved in cell signaling pathways. These include genes that are unique to the virus as well as viral homologues of cellular genes. The latter are likely to have been usurped from the host genome and include both virokines and viral receptor proteins. This article reviews how these KSHV proteins modulate cellular signal transduction pathways.
Similar content being viewed by others
References
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869.
Ganem, D. (1998) Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Curr. Clin. Top. Infect. Dis. 18, 237–251.
Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J., and Ganem, D. (1996) The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma- associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 2, 918–924.
Moore, P. S., and Chang, Y. (1995) Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl. J. Med. 332, 1181–1185.
Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl. J. Med. 332, 1186–1191.
Cesarman, E., and Knowles, D. M. (1997) Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Semin. Diagn. Pathol. 14, 54–66.
Albrecht, J. C., Nicholas, J., Biller, D., Cameron, K. R., Biesinger, B., Newman, C., et al. (1992) Primary structure of the herpesvirus saimiri genome. J. Virol. 66, 5047–5058.
Alexander, L., Denenkamp, L., Knapp, A., Auerbach, M., Czajak, S., Damania, B., et al. (2000) The primary sequence of rhesus rhadinovirus isolate 26–95: sequence similarities to Kaposi's sarcoma herpesvirus and rhesus rhadinovirus isolate 17577. J. Virol. 74, 3388–3398.
Searles, R. P., Bergquam, E. P., Axthelm, M. K., and Wong, S. W. (1999) Sequence and genomic analysis of a rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73, 3040–3053.
Virgin, H. W. T., Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J., et al. (1997) Complete sequence and genomic analysis of murine gamma herpesvirus 68. J. Virol. 71, 5894–5904.
Moore, P. S., and Chang, Y. (1995) Kaposi's sarcoma findings. Science 270, 5233, 15–16.
Staskus, K. A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R., et al. (1997) Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71, 715–719.
Gessain, A., Sudaka, A., Briere, J., Fouchard, N., Nicola, M. A., Rio, B., et al. (1996) Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 87, 414–416.
Neipel, F., Albrecht, J. C., and Fleckenstein, B. (1998) Human herpesvirus 8—the first human rhadinovirus. J. Natl. Cancer Inst. Monogr. 23, 73–77.
Pastore, C., Gloghini, A., Volpe, G., Nomdedeu, J., Leonardo, E., Mazza, U., et al. (1995) Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain. Br. J. Haematol. 91, 918–920.
Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., et al. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276–1280.
Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., et al. (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA 96, 4546–4551.
Mitterer, M., Mair, W., Gatti, D., Sheldon, J., Vachula, M., Coser, P., et al. (1998) Dendritic cells derived from bone marrow and CD34+ selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genome. Br J Haematol 102, 1338–1340.
Whitby, D., Boshoff, C., Luppi, M., and Torelli G. (1997) Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 278, 1971–1972; discussion 1972–1973.
Knowles, D. M., Inghirami, G., Ubriaco, A., and Dalla-Favera, R. (1989) Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 73, 792–799.
Boshoff, C., and Weiss, R. A. (1998) Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res 75, 57–86.
Drexler, H. G., Uphoff, C. C., Gaidano, G., and Carbone, A. (1998) Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 12, 1507–1517.
Kikuta, H., Itakura, O., Taneichi, K., and Kohno, M. (1997) Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. Br. J. Haematol. 99, 790–793.
Noel, J. C., Hermans, P., Andre, J., Fayt, I., Simonart, T., Verhest, A., et al. (1996) Herpesvirus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiology, clinical spectrum, and histologic features. Cancer 77, 2132–2136.
Flore, O., Rafii, S., Ely, S., O'Leary, J. J., Hyjek, E. M., and Cesarman, E. (1998) Transformation of primary human endothelial cells by Kaposi's sarcoma- associated herpesvirus. Nature 394, 588–592.
Desrosiers, R. C., Sasseville, V. G., Czajak, S. C., Zhang, X., Mansfield, K. G., Kaur, A., et al. (1997) A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J. Virol. 71, 9764–9769.
Greensill, J., Sheldon, J. A., Renwick, N. M., Beer, B. E., Norley, S., Goudsmit, J. et al. (2000) Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? J. Virol. 74, 1572–1577.
Rose, T. M., Strand, K. B., Schultz, E. R., Schaefer, G., Rankin, Jr., G. W., Thouless, M. E., et al. (1997) Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J. Virol. 71, 4138–4144.
Strand, K., Harper, E., Thormahlen, S., Thouless, M. E., Tsai, C., Rose, T., et al. (2000) Two distinct lineages of macaque gamma herpesviruses related to the Kaposi's sarcoma associated herpesvirus. J. Clin. Virol. 16, 253–269.
DeWire, S. M., McVoy, M. A., and Damania, B. (2002) Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes. J. Virol. 76, 9819–9831.
Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., et al. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93, 14862–14867.
Nicholas, J., Zong, J. C., Alcendor, D. J., Ciufo, D. M., Poole, L. J., Sarisky, R. T., et al. (1998) Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J. Natl. Cancer Inst. Monogr. 23, 79–88.
Damania, B., Choi, J. K., and Jung, J. U. (2000) Signaling activities of gamma herpesvirus membrane proteins. J. Virol. 74, 1593–1601.
Damania, B., and Jung, J. U. (2001) Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri. Adv. Cancer Res. 80, 51–82.
Damania, B., H. Lee, and J. U. Jung. (1999) Primate herpesviral oncogenes. Mol. Cells 9, 345–349.
Damania, B., Li, M., Choi, J. K., Alexander, L., Jung, J. U., and Desrosiers, R. C. (1999) Identification of the R1 oncogene and its protein product from the rhadinovirus of Rhesus monkeys. J. Virol. 73, 5123–5131.
Lee, H., Veazey, R., Williams, K., Li, M., Guo, J., Neipel, F., et al. (1998) Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat. Med. 4, 435–440.
Lagunoff, M., and Ganem, D. (1997) The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236, 147–154.
Poole, L. J., Zong, J. C., Ciufo, D. M., Alcendor, D. J., Cannon, J. S., et al. (1999) Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the righthand end. J. Virol. 73, 6646–6660.
Zong, J. C., Ciufo, D. M., Alcendor, D. J., Wan, X., Nicholas, J., Browning, P. J., et al. (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 73, 4156–4170.
Kasolo, F. C., Monze, M., Obel, N., Anderson, R. A., French, C., and Gompels, U. A. (1998) Sequence analyses of human herpesvirus-8 strains from both African human immunodeficiency virus-negative and-positive childhood endemic Kaposi's sarcoma show a close relationship with strains identified in febrile children and high variation in the K1 glycoprotein. J. Gen. Virol. 79, 3055–3065.
Nicholas, J., Ruvolo, V., Zong, J., Ciufo, D., Guo, H. G., Reitz, M. S., et al. (1997) A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71, 1963–1974.
Lagunoff, M., Majeti, R., Weiss, A., and Ganem, D. (1999) Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 96, 5704–5709.
Lee, H., Guo, J., Li, M., Choi, J. K., DeMaria, M., Rosenzweig, M., et al. (1998) Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell Biol. 18, 5219–5228.
Samaniego, F., Pati, S., Karp, J., Prakash, O., and Bose, D. (2001) Human herpesvirus 8 k1-associated nuclear factor-kappa b-dependent promoter activity: role in kaposi's sarcoma inflammation? J. Natl. Cancer Inst. Monogr. 28, 15–23.
Lagunoff, M., Lukac, D. M., and Ganem, D. (2001) Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J. Virol. 75, 5891–5898.
Lee, B. S., Paulose-Murphy, M., Chung, Y. H., Connlole, M., Zeichner, S., and Jung, J. U. (2002) Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J. Virol. 76, 12185–12199.
Bowser, B. S., DeWire, S. M., and Damania, B. (2002) Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76, 12574–12583.
Tomlinson, C. C. and Damania, B. (2003) The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway and targets the forkhead family of transcription factors. J. Virol. 78, 1918–1927.
Damania, B., DeMaria, M., Jung, J. U., and Desrosiers, R. C. (2000) Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus. J. Virol. 74, 2721–2730.
Prakash, O., Tang, Z. Y., Peng, X., Coleman, R., Gill, J., Farr, G., et al. (2002) Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 k1 gene. J. Natl. Cancer Inst. 94, 926–935.
Choi, J. K., Lee, B. S., Shim, S. N., Li, M., and Jung, J. U. (2000) Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J. Virol. 74, 436–446.
Glenn, M., Rainbow, L., Aurad, F., Davison, A., and Schulz, T. F. (1999) Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J. Virol. 73, 6953–6963.
Brinkmann, M. M., Glenn, M., Rainbow, L., Keiser, A., Henke-Gendo, C., and Schulz, T. T. (2003) Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J. Virol. 77, 9346–9358.
Sharp, T. V., Wang, H. W., Koumi, A., Hollyman, D., Endo, Y., Ye, H., et al. (2002) K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J. Virol. 76, 802–816.
DiMaio, D., Lai, C. C., and Klein, O. (1998) Virocrine transformation: the intersection between viral transforming proteins and cellular signal transduction pathways. Annu. Rev. Microbiol. 52, 397–421.
Cesarman, E., Nador, R. G., Bai, F., Bohenzky, R. A., Russo, J. J., Moore, P. S., et al. (1996) Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70, 8218–8223.
Guo H. G., Browning, P., Nicholas, J., Hayward, G. S., Tschachler, E., Jiang, Y. W., et al. (1997) Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology 228, 371–378.
Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C., and Cesarman, E. (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347–350.
Gershengorn, M. C., Geras-Raaka, E., Varma, A., and Clark-Lewis, I. (1998) Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture [see comments]. J. Clin. Invest. 102, 1469–1472.
Ho, H. H., Du, D., and Gershengorn, M. C. (1999) The N terminus of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity. J. Biol. Chem. 274, 31327–31332.
Geras-Raaka, E., Arvanitakis, L., Bais, C., Cesarman, E., Mesri, E. A., and Gershengorn, M. C. (1998) Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture. J. Exp. Med. 187, 801–806.
Geras-Raaka, E., Varma, A., Clark-Lewis, I., and Gershengorn, M. C. (1998) Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. Biochem. Biophys. Res. Commun. 253, 725–727.
Geras-Raaka, E., Varma, A., Ho, H., Clark-Lewis, I., and Gershengorn, M. C. (1998) Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Exp. Med. 188, 405–408.
Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86–89.
Bais, C., Van Geelen, A., Eroles, P., Mutlu, A., Chiozzini, C., Dias, S., et al. (2003) Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3, 131–143.
Couty, J. P., Geras-Raaka, E., Weksler, B. B., and Gershengorn, M. C. (2001) Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J. Biol. Chem. 276, 33805–33811.
Montaner, S., Sodhi, A., Molinolo, A., Bugge, T. H., Sawai, E. T., He, Y., et al. (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3, 23–36.
Montaner, S., Sodhi, A., Pece, S., Mesri, E. A., and Gutkind, J. S. (2001) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res. 61, 2641–2648.
Munshi, N., Ganju, R. K., Avraham, S., Mesri, E. A., and Groopman, J. E. (1999) Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. J. Biol. Chem. 274, 31863–31867.
Pati, S., Cavrois, M., Guo, H. G., Foulke, Jr. J. S., Kim, J., Feldman, R. A., et al. (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J. Virol. 75, 8660–8673.
Schwarz, M., and Murphy, P. M. (2001) Kaposi's sarcoma-associated herpesvirus g protein-coupled receptor constitutively activates nf-kappab and induces proinflammatory cytokine and chemokine production via a c-terminal signaling determinant. J. Immunol. 167, 505–513.
Smit, M. J., Verzijl, D., Casarosa, P., Navis, M., Timmerman, H., and Leurs, R. (2002) Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J. Virol. 76, 1744–1752.
Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., et al. (2000) The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60, 4873–4880.
Yang, T. Y., Chen, S. C., Leach, M. W., Manfra, D., Homey, B., Wiekowski, M., et al. (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191, 445–454.
Guo, H. G., Sadowska, M., Reid, W., Tschachler, E., Hayward, G., and Reitz, M. (2003) Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J. Virol. 77, 2631–2639.
Shepard, L. W., Yang, M., Xie, P., Browning, D. D., Vovno-Yasenetskaya, T., Kozasa, T., et al. (2001) Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus involve G alpha(13) and RhoA. J. Biol. Chem. 276, 45979–45987.
Polson, A. G., Wang, D., DeRisi, J., and Ganem, D. (2002) Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 62, 4525–4530.
Cannon, M., Philpott, N. J., and Cesarman, E. (2003) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J. Virol. 77, 57–67.
Moore, P. S., Boshoff, C., Weiss, R. A., and Chang, Y. (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739–1744.
Neipel, F., Albrecht, J. C., Ensser, A., Huang, Y. Q., Li, J. J., Friedman-Kien, A. E., et al. (1997) Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71, 839–842.
Nicholas, J., Ruvolo, V. R., Burns, W. H., Sandford, G., Wan, X., Ciufo, D., et al. (1997) Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3, 287–292.
Chatterjee, M., Osborne, J., Bestetti, G., Chang, Y., and Moore, P. S. (2002) Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432–1435.
Chow, D., He, X., Snow, A. L., Rose-John, S., and Garcia, K. C. (2001) Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291, 2150–2155.
Hideshima, T., Chauhan, D., Teoh, G., Raje, N., Treon, S. P., Tai, Y. T., et al. (2000) Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin. Cancer Res. 6, 1180–1189.
Klouche, M., Brockmeyer, N., Knabbe, C., and Rose-John, S. (2002) Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells. AIDS 16, F9-F18.
Li, H., and Nicholas, J. (2002) Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6. J. Virol. 76, 5627–5636.
Li, H., Wang, H., and Nicholas, J. (2001) Detection of direct binding of human herpesvirus 8-encoded interleukin- 6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and-independent signaling. J. Virol. 75, 3325–3334.
Molden, J., Chang, Y., You, Y., Moore, P. S., and Goldsmith, M. A. (1997) A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272, 19625–19631.
Mullberg, J., Geib, T., Jostock, T., Hoischen, S. H., Vollmer, P., Voltz, N., et al. (2000) IL-6 receptor independent stimulation of human gp130 by viral IL-6. J. Immunol. 164, 4672–4677.
Osborne, J., Moore, P. S., and Chang, Y. (1999) KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum. Immunol. 60, 921–927.
Wan, X., Wang, H., and Nicholas, J. (1999) Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J. Virol. 73, 8268–8278.
Foussat, A., Wijdenes, J., Bouchet, L., Gaidano, G., Neipel, F., Balabanian, K., et al. (1999) Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur. Cytokine Netw. 10, 501–508.
Mori, Y., Nishimoto, N., Ohno, M., Inagi, R., Dhepakson, P., Amou, K., et al. (2000) Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J. Med. Virol. 61, 332–335.
Parravinci, C., Corbellino, M., Paulli, M., Magrini, U., Lazzarino, M., Moore, P. S., et al. (1997) Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol. 151, 1517–1522.
Cannon, J. S., Nicholas, J., Orenstein, J. M., Mann, R. B., Murray, P. G., Browning, P. J., et al. (1999) Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J. Infect. Dis. 180, 824–828.
Staskus, K. A., Sun, R., Miller, G., Racz, P., Jaslowski, A., Metroka, C., et al. (1999) Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J. Virol. 73, 4181–4187.
Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F., and Miller, G. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 95, 10866–10871.
Aoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., et al. (1999) Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034–4043.
Liu, C., Okruzhnov, Y., Li, H., and Nicholas, J. (2001) Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J. Virol. 75, 10933–10940.
Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., et al. (1997) Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290–294.
Dairaghi, D. J., Franz-Bacon, K., Callas, E., Cupp, J., Schall, T. J., Tamraz, S. A., et al. (1998) Macrophage inflammatory preotein-1beta induces migration and activation of human thymocytes. Blood 91, 2905–2913.
Haque, N. S., Fallon, J. T., Taubman, M. B., and Harpel, P. C. (2001) The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood 97, 39–45.
Sozzani, S., Luini, W., Bianchi, G., Allavena, P., Wells, T. N., Napolitano, M., et al. (1998) The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92, 4036–4039.
Weber, K. S., Grone, H. J., Rocken, M., Klier, C., Gu, S., Wank, R., et al. (2001) Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur. J. Immunol. 31, 2458–2466.
Nakano, K., Isegawa, Y., Zou, P., Tadagaki, K., Inagi, R., and Yamanishi, K. (2003) Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Arch. Virol. 148, 871–890.
Kledal, T. N., Rosenkilde, M. M., Coulin, F., Simmons, G., Johnsen, A. H., Alouani, S., et al. (1997) A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277, 1656–1659.
Chang, J., Renne, R., Dittmer, D., and Ganem, D. (2000) Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 266, 17–25.
Dittmer, D., and Kedes, D. H. (1998) Do viral chemokines modulate Kaposi's sarcoma? Bioessays 20, 367–70.
Burysek, L., and Pitha, P. M. (2001) Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J. Virol. 75, 2345–2352.
Li, M., Lee, H., Guo, J., Neipel, F., Fleckenstein, B., Ozato, K., et al. (1998) Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J. Virol. 72, 5433–5440.
Lubyova, B., and Pitha, P. M. (2000) Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74, 8194–8201.
Rivas, C., Thlick, A. E., Parravicini, C., Moore, P. S., and Chang, Y. (2001) Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429–438.
Zimring, J. C., Goodbourn, S., and Offermann, M. K. (1998) Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72, 701–707.
Gao, S. J., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y., and Moore, P. S. (1997) KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979–85.
Seo, T., Lee, D., Lee, B., Chung, J. H., and Choe, J. (2000) viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem. Biophys. Res. Commun. 270, 23–27.
Burysek, L., Yeow, W. S., Lubyova, B., Kellum, M., Schafer, S. L., Huang, Y. Q., et al. (1999) Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 73, 7334–7342.
Burysek, L., Yeow, W. S., and Pitha, P. M. (1999) Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). Hum. Virol. 2, 19–32.
Jayachandra, S., Low, K. G., Thlick, A. E., Yu, J., Ling, P. D., Chang, Y., et al. (1999) Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc. Natl. Acad. Sci. USA 96, 11566–11571.
Nakamura, H., Li, M., Zarycki, J., and Jung, J. U. (2001) Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J. Virol. 75, 7572–7582.
Dittmer, D. P. (2003) Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res. 63, 2010–2015.
Ballestas, M. E., Chatis, P. A., and Kaye, K. M. (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641–644.
Cotter, M. A., 2nd, and Robertson, E. S. (1999) The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254–264.
Cotter, M. A., 2nd, Subramanian, C., and Robertson, E. S. (2001) The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291, 241–259.
Garber, A. C., Hu, J., and Renne, R. (2002) Lana cooperatively binds to two sites within the terminal repeat, both sites contribute to lana's ability to suppress transcription and facilitate DNA replication. J. Biol. Chem. 277, 27401–27411.
Garber, A. C., Shu, M. A., Hu, J., and Renne, R. (2001) DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75, 7882–7892.
Grundhoff, A., and D. Ganem (2003) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77, 2779–2783.
Friborg, J., Jr., Kong, W., Hottiger, M. O., and Nabel, G. J. (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889–894.
Platt, G. M., Simpson, G. R., Mittnacht, S., and Schulz, T. F. (1999) Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J. Virol. 73, 9789–9795.
Radkov, S. A., Kellam, P., and Boshoff, C. (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121–1127.
Li, M., Lee, H., Yoon, D. W., Albrecht, J. C., Fleckenstein, B., Neipel, F., and Jung, J. U. (1997) Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71, 1984–1991.
Schulze-Gahmen, U., Jung, J. U., and Kim, S. H. (1999) Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. Structure 7, 245–254.
Ellis, M., Y. P. Chew, L. Fallis, S. Freddersdorf, C. Boshoff, R. A. Weiss, X. Lu, and S. Mittnacht. (1999) Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 18, 644–653.
Godden-Kent, D., Talbot, S. J., Boshoff, C., Chang, Y., Moore, P., Weiss, R. A., et al. (1997) The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 71, 4193–4198.
Mann, D. J., Child, E. S., Swanton, C., Laman, H., and Jones, N. (1999) Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J. 18, 654–663.
Ojala, P. M., Yamamoto, K., Castanos-Velez, E., Biberfeld, P., Korsmeyer, S. J., and Makela, T. P. (2000) The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 2, 819–825.
Lundquist, A., Barre, B., Bienvenu, F., Hermann, J., Avril, S., and Coqueret, O. (2003) Kaposi's sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood. 101, 4070–4077.
Verschuren, E. W., Klefstrom, J., Evan, G. I., and Jones, N. (2002) The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2, 229–241.
Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517–521.
Field, N., W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, and M. Collins. (2003) KSHV vFLIP binds to IKK-γ to activate IKK. J. Cell Sci. 116, 3721–3728.
Liu, L., Eby, M. T., Rathore, N., Sinha, S. K., Kumar, A., and Chaudhary, P. M. (2002) The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277, 13745–13751.
An, J., Sun, Y., Sun, R., and Rettig, M. B. (2003) Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene 22, 3371–3385.
Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B., et al. (1999) A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73, 5722–5730.
Kliche, S., Nagel, W., Kremmer, E., Atzler, C., Ege, A., Knorr, T., et al. (2001) Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol. Cell 7, 833–843.
Muralidhar, S., Pumfery, A. M., Hassani, M., Sadaie, M. R., Azumi, N., Kishishita, M., et al. (1998) Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72, 4980–4988.
Muralidhar, S., Veytsmann, G., Chandran, B., Ablashi, D., Doniger, J., and Rosenthal, L. J. (2000) Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J. Clin. Virol. 16, 203–213.
Wang, L., Wakisaka, N., Tomlinson, C. C., DeWire, S., Krall, S., Pagano, J. S., and Damania, B. (2004) The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64, 120–128.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Damania, B. Modulation of cell signaling pathways by kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). Cell Biochem Biophys 40, 305–322 (2004). https://doi.org/10.1385/CBB:40:3:305
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/CBB:40:3:305